African Journal of Cardiology and Cardiovascular Medicine
Editor-in-Chief: Dr. Mohd. Shahbaaz Khan | ISSN: 3136-9294 | Frequency: Biannual | Publication Format: Open Access | Language: English | Indexing/Listing :

Current Issue of African Journal of Cardiology and Cardiovascular Medicine

Volume 2, Issue 1, January 2026
Review Article

Direct oral anticoagulants versus left atrial appendage occlusion for stroke prevention in atrial fibrillation: A systematic review and meta-analysis

| Open Access

Moana T. Rangi1*

Afj.Card.Cardvm. 2(1) (2026) 37-45, DOI: https://doi.org/10.62587/AFJCCM.2.1.2026.37-45
Received: 28/08/2025|Accepted: 03/12/2025|Published: 25/01/2026

Abstract

Background: Direct oral anticoagulants (DOACs) constitute the pharmacological standard for stroke prevention in atrial fibrillation, yet a meaningful proportion of patients face contraindications, recurrent bleeding, or thromboembolic events despite treatment. Left Atrial Appendage Occlusion (LAAO) offers a device-based alternative, and this systematic review and meta-analysis aimed to compare the efficacy and safety of DOACs and LAAO for stroke prevention in atrial fibrillation. Methods: PubMed, Scopus, Embase, and the Cochrane Central Register of Controlled Trials were searched to December 2025 for randomized trials and propensity-matched cohorts directly comparing LAAO with DOACs. Six studies were included. Random-effects models with the DerSimonian and Laird estimator generated pooled Odds Ratios (ORs) for ischemic stroke, major bleeding, and all-cause mortality, expressed for LAAO relative to DOAC, with heterogeneity assessed using the I-squared statistic. Results: Ischemic stroke was numerically more frequent with LAAO without reaching significance (OR 1.44, 95% CI 0.86 to 2.42; I-squared 34%). Major bleeding was significantly lower with LAAO (OR 0.78, 95% CI 0.64 to 0.95; Isquared 12%), as was all-cause mortality (OR 0.82, 95% CI 0.72 to 0.93; I-squared 0%). The findings were consistent across the randomized and propensity matched evidence and reflect a coherent trade-off between thromboembolic protection and bleeding avoidance. Conclusion: Relative to DOACs, LAAO conferred comparable but possibly less complete protection against ischemic stroke, offset by significant reductions in major bleeding and all-cause mortality. These findings support LAAO as a reasonable alternative for selected patients unsuited to long-term anticoagulation, while underscoring the need for adequately powered randomized trials in the broader atrial fibrillation population.


Keywords: Atrial fibrillation, Left atrial appendage occlusion, Direct oral anticoagulants, Stroke prevention, Major bleeding, Meta-analysis

 Full text  Download  XML